Vanguard Asset Management
PLSE icon

Vanguard Asset Management’s Pulse Biosciences PLSE Stock Holding History

Vanguard Asset Management’s Portfolio PLSE Stock Details PLSE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$579K Hold
11,602
– – ﹤0.01% 2114
2026
Q2 		$322K Hold
11,602
– – ﹤0.01% 2323
2026
Q1 		$250K Buy
+11,602
New +$214K ﹤0.01% 2327

Other funds holding PLSE

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $296B AUM 23.14% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $33.4B AUM 56.97% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $71.4B AUM 33.43% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $116B AUM 33.19% 1-Year Est. Return

Vanguard Asset Management's PLSE Position: Q3 2026 in Review

Vanguard Asset Management held its Pulse Biosciences (PLSE) position steady in Q3 2026 at 11,602 shares worth $579K. The position accounts for ﹤0.01% of the portfolio, ranked #2114.

Vanguard Asset Management first reported a position in PLSE in Q1 2026 and has held it in 3 quarters since. 97 funds tracked by Wall St. Rank hold PLSE as of Q3 2026.

  • Vanguard Asset Management held 11,602 shares of Pulse Biosciences worth $579K as of Q3 2026.
  • Vanguard Asset Management left its Pulse Biosciences share count unchanged in Q3 2026.
  • Pulse Biosciences made up ﹤0.01% of Vanguard Asset Management's portfolio in Q3 2026, its #2114 holding.
  • Vanguard Asset Management first reported a position in Pulse Biosciences in Q1 2026 and has held it in 3 quarters since.
  • 97 funds tracked by Wall St. Rank held Pulse Biosciences as of Q3 2026.

Based on Vanguard Asset Management's 13F filing for Q3 2026, filed 13 Nov 2026.